Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 16, 2021
Total Value: $2.668B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GHRS | GH RESEARCH PLC | 9,275,156 | $202M | 7.6% | — | — | ORDINARY SHARES | G3855L106 |
| ARGX | ARGENX SE | 651,204 | $196M | 7.3% | — | — | SPONSORED ADR | 04016X101 |
| OLMA | OLEMA PHARMACEUTICALS INC | 6,661,503 | $186M | 7.0% | — | — | COM | 68062P106 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 3,754,095 | $168M | 6.3% | — | — | COM | 74366E102 |
| — | MERUS N V | 7,285,071 | $153M | 5.8% | — | — | COM | N5749R100 |
| KYMR | KYMERA THERAPEUTICS INC | 2,630,658 | $128M | 4.8% | — | — | COM | 501575104 |
| XOMA | XOMA CORP DEL | 3,530,543 | $120M | 4.5% | — | — | COM NEW | 98419J206 |
| — | REPARE THERAPEUTICS INC | 3,722,398 | $116M | 4.3% | — | — | COM | 760273102 |
| RLAY | RELAY THERAPEUTICS INC | 2,938,202 | $108M | 4.0% | — | — | COM | 75943R102 |
| RVMD | REVOLUTION MEDICINES INC | 2,485,049 | $78.88M | 3.0% | — | — | COM | 76155X100 |
| RCUS | ARCUS BIOSCIENCES INC | 2,797,822 | $76.83M | 2.9% | — | — | COM | 03969F109 |
| — | ESSA PHARMA INC | 2,451,561 | $70.04M | 2.6% | — | — | COM NEW | 29668H708 |
| ACIU | AC IMMUNE SA | 8,545,179 | $67.76M | 2.5% | — | — | SHS | H00263105 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 2,005,862 | $48.3M | 1.8% | — | — | COM | 35104E100 |
| — | VERASTEM INC | 11,286,258 | $45.94M | 1.7% | — | — | COM | 92337C104 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 2,486,429 | $42.69M | 1.6% | — | — | COM | 87164F105 |
| LXRX | LEXICON PHARMACEUTICALS INC | 8,394,000 | $38.53M | 1.4% | — | — | COM NEW | 528872302 |
| REPL | REPLIMUNE GROUP INC | 918,928 | $35.3M | 1.3% | — | — | COM | 76029N106 |
| — | VIRACTA THERAPEUTICS INC | 3,094,174 | $35.09M | 1.3% | — | — | COM | 92765F108 |
| KURA | KURA ONCOLOGY INC | 1,635,112 | $34.09M | 1.3% | — | — | COM | 50127T109 |
| — | RAIN THERAPEUTICS INC | 1,945,949 | $30.24M | 1.1% | — | — | COM | 75082Q105 |
| SPRO | SPERO THERAPEUTICS INC | 2,137,978 | $29.85M | 1.1% | — | — | COM | 84833T103 |
| JANX | JANUX THERAPEUTICS INC | 1,176,681 | $29.36M | 1.1% | — | — | COM | 47103J105 |
| XENE | XENON PHARMACEUTICALS INC | 1,571,778 | $29.27M | 1.1% | — | — | COM | 98420N105 |
| — | THERAPEUTICS ACQUISITION COR | 2,772,226 | $28.5M | 1.1% | — | — | COM CL A | 88339T103 |
| OVID | OVID THERAPEUTICS INC | 6,631,051 | $25.93M | 1.0% | — | — | COM | 690469101 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 8,383,645 | $25.07M | 0.9% | — | — | COM | 45665G303 |
| — | IKENA ONCOLOGY INC | 1,767,399 | $24.81M | 0.9% | — | — | COM | 45175G108 |
| — | MOLECULAR TEMPLATES INC | 2,856,599 | $22.34M | 0.8% | — | — | COM | 608550109 |
| — | CTI BIOPHARMA CORP | 8,929,690 | $22.32M | 0.8% | — | — | COM | 12648L601 |
| — | GLYCOMIMETICS INC | 9,544,262 | $22.14M | 0.8% | — | — | COM | 38000Q102 |
| — | CALLIDITAS THERAPEUTICS AB | 750,000 | $22.08M | 0.8% | — | — | SPONSERED ADS | 13124Q106 |
| — | ELEVATION ONCOLOGY INC | 1,590,291 | $21.58M | 0.8% | — | — | COM | 28623U101 |
| ANAB | ANAPTYSBIO INC | 808,710 | $20.97M | 0.8% | — | — | COM | 032724106 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 918,975 | $20.93M | 0.8% | — | — | COM | 23954D109 |
| — | PIERIS PHARMACEUTICALS INC | 5,328,239 | $20.41M | 0.8% | — | — | COM | 720795103 |
| — | FORTE BIOSCIENCES INC | 591,811 | $19.9M | 0.7% | — | — | COM | 34962G109 |
| CGEM | CULLINAN ONCOLOGY INC | 735,106 | $18.93M | 0.7% | — | — | COM | 230031106 |
| — | NGM BIOPHARMACEUTICALS INC | 955,000 | $18.83M | 0.7% | — | — | COM | 62921N105 |
| ACRS | ACLARIS THERAPEUTICS INC | 1,000,000 | $17.56M | 0.7% | — | — | COM | 00461U105 |
| — | CONTRAFECT CORP | 3,972,300 | $17.48M | 0.7% | — | — | COM NEW | 212326300 |
| SLN | SILENCE THERAPEUTICS PLC | 666,666 | $17.01M | 0.6% | — | — | ADS | 82686Q101 |
| — | GRITSTONE BIO INC | 1,826,494 | $16.68M | 0.6% | — | — | COM | 39868T105 |
| — | SUTRO BIOPHARMA INC | 826,825 | $15.37M | 0.6% | — | — | COM | 869367102 |
| — | CALITHERA BIOSCIENCES INC | 7,299,331 | $15.26M | 0.6% | — | — | COM | 13089P101 |
| — | ANGION BIOMEDICA CORP | 1,036,500 | $13.49M | 0.5% | — | — | COM | 03476J107 |
| IMVT | IMMUNOVANT INC | 1,273,516 | $13.46M | 0.5% | — | — | COM | 45258J102 |
| COGT | COGENT BIOSCIENCES | 1,532,282 | $12.43M | 0.5% | — | — | COM | 19240Q201 |
| — | MEI PHARMA INC | 3,532,057 | $10.07M | 0.4% | — | — | COM NEW | 55279B202 |
| CRVS | CORVUS PHARMACEUTICALS INC | 3,678,626 | $9.822M | 0.4% | — | — | COM | 221015100 |
| GNCAQ | GENOCEA BIOSCIENCES INC | 4,012,404 | $9.389M | 0.4% | — | — | COM NEW | 372427401 |
| ELDN | ELEDON PHARMACEUTICALS INC | 1,113,435 | $8.807M | 0.3% | — | — | COM | 28617K101 |
| — | CIDARA THERAPEUTICS INC | 4,346,904 | $8.781M | 0.3% | — | — | COM | 171757107 |
| — | AMARIN CORP PLC | 1,715,981 | $7.516M | 0.3% | — | — | SPONS ADR NEW | 023111206 |
| — | SELECTA BIOSCIENCES INC | 1,693,456 | $7.079M | 0.3% | — | — | COM | 816212104 |
| — | AILERON THERAPEUTICS INC | 5,265,555 | $6.582M | 0.2% | — | — | COM | 00887A105 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 350,081 | $6.403M | 0.2% | — | — | COM | 92790C104 |
| — | ERYTECH PHARMA | 1,314,656 | $6.376M | 0.2% | — | — | SPONSORED ADR | 29604W108 |
| — | X4 PHARMACEUTICALS INC | 847,879 | $5.511M | 0.2% | — | — | COM | 98420X103 |
| — | GALMED PHARMACEUTICALS LTD | 1,799,694 | $5.471M | 0.2% | — | — | SHS | M47238106 |
| — | EUCRATES BIOMEDICAL ACQU COR | 500,000 | $5.095M | 0.2% | — | — | UNIT 10/23/2027 | G3141W114 |
| — | FRAZIER LIFESCIENCES ACQU CO | 500,000 | $5.04M | 0.2% | — | — | UNIT 12/09/2025 | G3710A121 |
| — | RESEARCH ALLIANCE CORP II | 500,000 | $5M | 0.2% | — | — | COM CL A | 760873109 |
| — | 5 01 ACQUISITION CORP | 500,000 | $4.985M | 0.2% | — | — | COM CL A | 33836P105 |
| — | FORWARD PHARMA A/S | 528,514 | $4.545M | 0.2% | — | — | SPONSORD ADS NEW | 34986J204 |
| — | JIYA ACQUISITION CORP | 300,000 | $2.982M | 0.1% | — | — | COM CL A | 47760M102 |
| RZLT | REZOLUTE INC | 190,815 | $2.723M | 0.1% | — | — | COM NEW | 76200L309 |
| IVA | INVENTIVA SA | 107,000 | $1.455M | 0.1% | — | — | ADS | 46124U107 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 58,900 | $1.308M | 0.0% | — | — | SPONSORED ADS | 152309100 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 24,280 | $458K | 0.0% | — | — | COM | 22663K107 |